Disease Prevention

HHS assists states with antiviral drug purchases for influenza

Published in Medical Letter on the CDC and FDA, August 6th, 2006

HHS Secretary Mike Leavitt announced a contract award with Roche Laboratories, Inc. to provide oseltamivir phosphate (Tamiflu) to all 50 states, the District of Columbia, five U.S. territories and the three Freely Associated States of the Pacific at a federally subsidized price.

The contract will run for a period of two years with a total contract award amount of $149,110,000.

"Our ultimate goal is to stockpile sufficient quantities of antiviral drugs to treat 25% of the U.S. population," Leavitt said. "Helping the states develop their own medical stockpiles will facilitate quicker distribution of antiviral drugs in the event of a pandemic influenza...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2006-08-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry